MX9708425A - Azocompuestos para el diagnostico antes de la muerte de la enfermedad de alzheimer y conocimiento y prevencion in vivo del deposito de amiloides. - Google Patents
Azocompuestos para el diagnostico antes de la muerte de la enfermedad de alzheimer y conocimiento y prevencion in vivo del deposito de amiloides.Info
- Publication number
- MX9708425A MX9708425A MX9708425A MX9708425A MX9708425A MX 9708425 A MX9708425 A MX 9708425A MX 9708425 A MX9708425 A MX 9708425A MX 9708425 A MX9708425 A MX 9708425A MX 9708425 A MX9708425 A MX 9708425A
- Authority
- MX
- Mexico
- Prior art keywords
- chrysamine
- derivatives
- methods
- alzheimer
- azocompounds
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 230000003941 amyloidogenesis Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000011503 in vivo imaging Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- XFFSCOOTVXBLCK-QAVVBOBSSA-N OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)-c1ccc(cc1)\N=N\c1ccc(O)c(c1)C(O)=O Chemical class OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)-c1ccc(cc1)\N=N\c1ccc(O)c(c1)C(O)=O XFFSCOOTVXBLCK-QAVVBOBSSA-N 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 208000037259 Amyloid Plaque Diseases 0.000 abstract 2
- 206010002022 amyloidosis Diseases 0.000 abstract 2
- 238000001574 biopsy Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 201000010374 Down Syndrome Diseases 0.000 abstract 1
- 206010044688 Trisomy 21 Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/10—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Se describen compuestos de union de amiloides que son derivados de composiciones farmacéuticas que contienen Crisamina G y métodos que usan dichos compuestos para identificar in vivo el cerebro con Alzheimer y para diagnosticar otras condiciones patologicas caracterizadas por amiloidosis, tales como Síndrome de Down. También se describen composiciones farmacéuticas que contienen Crisamina G y derivados de las mismas y métodos que usan dichas composiciones para evitar la degeneracion celular y la toxicidad inducida por amiloides en condiciones asociadas con amiloidosis. Así mismo, se describen métodos que usan derivados de Crisamina G para teñir o detectar depositos de amiloides en tejido de biopsia o ya muerto. También se describen métodos que usan derivados de crisamina G para cuantificar depositos que usan derivados de Crisamina G para cuantificar depositos de amiloides en homogenatos de tejido de biopsia y ya muerto.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43201995A | 1995-05-01 | 1995-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9708425A true MX9708425A (es) | 1998-08-30 |
Family
ID=23714410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9708425A MX9708425A (es) | 1995-05-01 | 1997-10-31 | Azocompuestos para el diagnostico antes de la muerte de la enfermedad de alzheimer y conocimiento y prevencion in vivo del deposito de amiloides. |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP1110945A3 (es) |
JP (1) | JPH11505526A (es) |
KR (1) | KR19990008328A (es) |
AU (1) | AU712552B2 (es) |
CA (1) | CA2219880A1 (es) |
HU (1) | HUP9900426A3 (es) |
MX (1) | MX9708425A (es) |
NO (1) | NO975002L (es) |
NZ (1) | NZ307369A (es) |
WO (1) | WO1996034853A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6168776B1 (en) | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
US6417178B1 (en) * | 1994-07-19 | 2002-07-09 | University Of Pittsburgh | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
WO1997041856A1 (en) * | 1996-05-08 | 1997-11-13 | Massachusetts Institute Of Technology | ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO) |
AU7221698A (en) * | 1997-04-29 | 1998-11-24 | Nycomed Imaging As | Light imaging contrast agents |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
PT1334091E (pt) | 2000-08-24 | 2013-01-07 | Univ Pittsburgh | Derivados de tioflavina e seu uso no diagnóstico e terapia da doença de alzheimer |
US6589504B1 (en) | 2000-09-22 | 2003-07-08 | Pharmacia & Upjohn Company | Compounds and methods for diagnosing and treating amyloid-related conditions |
US7029655B2 (en) * | 2000-10-04 | 2006-04-18 | California Institute Of Technology | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
US6479528B1 (en) * | 2001-07-31 | 2002-11-12 | Neuronautics, Inc. | Methods for inhibiting or reversing tau filament formation polymerization |
CA2473102A1 (en) * | 2002-01-29 | 2003-07-29 | Protemix Corporation Limited | Suppression of cytotoxic protein conformers |
GB0307855D0 (en) | 2003-04-04 | 2003-05-14 | Novartis Ag | Organic compounds |
EP1814876A2 (en) * | 2004-07-15 | 2007-08-08 | The General Hospital Corporation | Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
JP2007084526A (ja) * | 2004-11-26 | 2007-04-05 | Nagasaki Univ | アミロイド関連疾患診断用組成物 |
EP1875239B1 (en) * | 2005-04-27 | 2011-10-05 | Siemens Medical Solutions USA, Inc. | A method for the preparation of imaging probes using click chemistry |
WO2008078424A1 (ja) | 2006-12-25 | 2008-07-03 | Tohoku University | ベンゾキサゾール誘導体 |
WO2011076825A1 (en) * | 2009-12-23 | 2011-06-30 | Bayer Schering Pharma Aktiengesellschaft | Formulations suitable for pet imaging with hydrophobic pet agents |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58174459A (ja) * | 1982-04-06 | 1983-10-13 | Canon Inc | 記録液及びこれを用いたインクジェット記録方法 |
JPS59100450A (ja) * | 1982-11-30 | 1984-06-09 | Mitsubishi Paper Mills Ltd | 電子写真用感光体 |
JPS60205454A (ja) * | 1984-03-29 | 1985-10-17 | Mitsubishi Paper Mills Ltd | 電子写真感光体 |
AU620327B2 (en) * | 1987-04-08 | 1992-02-20 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
US5039511A (en) * | 1987-04-08 | 1991-08-13 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
US4933156A (en) * | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
JPS63301047A (ja) * | 1987-05-30 | 1988-12-08 | Toshiba Corp | 積層型正帯電電子写真感光体 |
JPS63301045A (ja) * | 1987-05-30 | 1988-12-08 | Toshiba Corp | 正帯電電子写真感光体 |
US5276059A (en) * | 1992-07-10 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of diseases associated with amyloid formation |
-
1996
- 1996-05-01 WO PCT/US1996/005918 patent/WO1996034853A1/en not_active Application Discontinuation
- 1996-05-01 EP EP01103705A patent/EP1110945A3/en not_active Withdrawn
- 1996-05-01 JP JP8533383A patent/JPH11505526A/ja active Pending
- 1996-05-01 CA CA002219880A patent/CA2219880A1/en not_active Abandoned
- 1996-05-01 EP EP96913856A patent/EP0823894A1/en not_active Ceased
- 1996-05-01 NZ NZ307369A patent/NZ307369A/xx unknown
- 1996-05-01 HU HU9900426A patent/HUP9900426A3/hu unknown
- 1996-05-01 AU AU56692/96A patent/AU712552B2/en not_active Ceased
- 1996-05-01 KR KR1019970707854A patent/KR19990008328A/ko not_active Application Discontinuation
-
1997
- 1997-10-30 NO NO975002A patent/NO975002L/no not_active Application Discontinuation
- 1997-10-31 MX MX9708425A patent/MX9708425A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU712552B2 (en) | 1999-11-11 |
WO1996034853A1 (en) | 1996-11-07 |
JPH11505526A (ja) | 1999-05-21 |
EP0823894A1 (en) | 1998-02-18 |
EP1110945A2 (en) | 2001-06-27 |
NZ307369A (en) | 1999-11-29 |
HUP9900426A2 (hu) | 1999-05-28 |
CA2219880A1 (en) | 1996-11-07 |
KR19990008328A (ko) | 1999-01-25 |
NO975002D0 (no) | 1997-10-30 |
NO975002L (no) | 1998-01-02 |
HUP9900426A3 (en) | 2001-12-28 |
AU5669296A (en) | 1996-11-21 |
EP1110945A3 (en) | 2003-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999024394A3 (en) | Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
TR199903115T2 (xx) | Alzheimer hastal���n�n te�hisi ve amiloid depozisyonunun imgelenmesi, engellenmesi. | |
NZ307369A (en) | Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
EE04298B1 (et) | Perfluoroalküülrühma sisaldavad metallikompleksidja nende kasutamine TMR-diagnostikas | |
WO2001046700A3 (en) | Sodium channels as targets for amyloid beta | |
WO2001087354A3 (en) | Use of small molecule radioligands for diagnostic imaging | |
HK1016877A1 (en) | Bioactivated diagnostic imaging contrast agents. | |
FR2377376A1 (fr) | Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides | |
TNSN99169A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
AU3891499A (en) | Diagnostic tests for alzheimer's disease | |
TNSN97110A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
WO1996034853B1 (en) | Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition | |
CA2263961A1 (en) | Cocaine receptor binding ligands | |
AU2001239544A1 (en) | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same | |
AU2002350950A1 (en) | Compounds for imaging alzheimer's disease | |
Boullin et al. | Towards the resolution of conflicting findings. | |
WO2002044144A3 (en) | Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds | |
BR0116865A (pt) | Composição compreendendo bisfosfonatos para prevenção e/ou tratamento de doenças metabólicas dos ossos, processo para preparar tal composição e uso desta | |
Komsta et al. | Tissue distribution metabolism and excretion of 2, 2′, 4, 4′, 5-pentachlorodiphenyl ether in the rat | |
EP1048302A3 (en) | Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease | |
WO2001064872A3 (en) | Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease | |
Kahana | The aging of personality types in medical management: Advances and setbacks. |